Cerebrospinal fluid β-amyloid1–42 and tau in control subjects at risk for Alzheimer’s disease: The effect of APOE ε4 allele-Reference-Cited by-同舟云学术

Cerebrospinal fluid β-amyloid1–42 and tau in control subjects at risk for Alzheimer’s disease: The effect of APOE ε4 allele

Published:2004-11 Issue:9 Volume:56 Page:670-676
ISSN:0006-3223
Container-title:Biological Psychiatry
language:en
Short-container-title:Biological Psychiatry

Author:

Sunderland Trey,Mirza Nadeem,Putnam Karen T.,Linker Gary,Bhupali Deepa,Durham Rob,Soares Holly,Kimmel Lida,Friedman David,Bergeson Judy,Csako Gyorgy,Levy James A.,Bartko John J.,Cohen Robert M.

Publisher

Elsevier BV

Subject

Biological Psychiatry

Reference50 articles.

1. Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice;Andreasen;Arch Neurol,2001

2. Predicting premorbid IQ;Blair;Clin Neuropsychol,1989

3. Cerebrospinal fluid protein biomarkers for Alzheimer’s disease;Blennow;J Am Soc Exp Neurother,2004

4. Neuropathological staging of Alzheimer-related changes;Braak;Acta Neuropathol Appl Neurobiol,1991

5. Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231;Buerger;Arch Neurol,2002

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in blood biomarkers for Alzheimer disease (AD): A review;The Kaohsiung Journal of Medical Sciences;2024-06-18

2. Prominent Perspective on Existing Biological Hallmarks of Alzheimer’s Disease;Current Topics in Medicinal Chemistry;2024-05

3. Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease;Annals of Neurology;2024-01-05

4. Tau: a biomarker of Huntington’s disease;Molecular Psychiatry;2023-09-25

5. More than just risk for Alzheimer’s disease: APOE ε4's impact on the aging brain;Trends in Neurosciences;2023-09